Certified by Founder Lodge
adMare BioInnovations
Canada - ND
INVESTOR
1 Disclosed Funding Rounds $142,000,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
With offices in Montreal, Vancouver and Toronto, adMare is building Canada’s life science industry from sea to sea. With a strong track record of globally-competitive scientific discovery, Ca
| Company | Date | Round | Raised |
|---|---|---|---|
 Abdera Therapeutics |
April, 24 ,2023 | Series B | $142,000,000 |
 Specific Biologics |
October, 17 ,2023 | Unknown |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
IORGANBIO | $2,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
